- Home
- UTMD vs INBX Comparison
UTMD vs INBX Comparison
Compare UTMD & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- INBX
- Stock Information
- Founded
- UTMD 1978
- INBX 2010
- Country
- UTMD United States
- INBX United States
- Employees
- UTMD N/A
- INBX N/A
- Industry
- UTMD Medical/Dental Instruments
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- UTMD Health Care
- INBX Health Care
- Exchange
- UTMD Nasdaq
- INBX Nasdaq
- Market Cap
- UTMD 171.3M
- INBX 178.5M
- IPO Year
- UTMD N/A
- INBX 2020
- Fundamental
- Price
- UTMD $54.73
- INBX $12.96
- Analyst Decision
- UTMD
- INBX Hold
- Analyst Count
- UTMD 0
- INBX 1
- Target Price
- UTMD N/A
- INBX N/A
- AVG Volume (30 Days)
- UTMD 12.3K
- INBX 97.1K
- Earning Date
- UTMD 07-24-2025
- INBX 05-14-2025
- Dividend Yield
- UTMD 2.25%
- INBX N/A
- EPS Growth
- UTMD N/A
- INBX N/A
- EPS
- UTMD 3.78
- INBX 111.58
- Revenue
- UTMD $39,273,000.00
- INBX $200,000.00
- Revenue This Year
- UTMD N/A
- INBX N/A
- Revenue Next Year
- UTMD N/A
- INBX N/A
- P/E Ratio
- UTMD $14.56
- INBX $0.12
- Revenue Growth
- UTMD N/A
- INBX N/A
- 52 Week Low
- UTMD $51.26
- INBX $10.80
- 52 Week High
- UTMD $77.33
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- UTMD 54.45
- INBX 53.73
- Support Level
- UTMD $52.98
- INBX $12.25
- Resistance Level
- UTMD $55.50
- INBX $13.88
- Average True Range (ATR)
- UTMD 1.31
- INBX 0.71
- MACD
- UTMD 0.14
- INBX 0.15
- Stochastic Oscillator
- UTMD 61.19
- INBX 69.85
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.